What is TOBI®?
TOBI® (tobramycin solution for inhalation ) is an antibiotic indicated for the
management of cystic fibrosis (CF) patients with Pseudomonas aeruginosa , a type
of bacteria frequently found in the lungs of a person with cystic fibrosis. TOBI
is designed for inhalation.
Each ready-to-use ampule of TOBI contains 300 mg of tobramycin in a 5 mL
solution. TOBI is administered using a PARI LC PLUS™ Reusable Nebulizer and a
DeVilbiss Pulmo-Aide® air compressor in repeated cycles of 28 days on drug, 28
days off drug. It is inhaled twice daily and requires about 15 minutes each
time. The dose is the same for all patients regardless of weight, age or other
factors. For instructions on how to use TOBI, see the Patient Medication Guide.